Silodosin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Silodosin" in English language version.

refsWebsite

Global rank English rank

3europa.eu

68^th place

117^th place

3nih.gov

4^th place

2tga.gov.au

3,984^th place

2,622^nd place

2fda.gov

447^th place

338^th place

1hres.ca

low place

1doi.org

2^nd place

1kissei.co.jp

low place

1biospace.com

low place

7,595^th place

1drugs.com

399^th place

333^rd place

biospace.com

"Watson Pharmaceuticals, Inc. Announces Agreement With Kissei Pharmaceutical Co., Ltd. For Novel Urology Drug Candidate". BioSpace. 22 April 2004. Retrieved 5 March 2023.

doi.org

Kobayashi K, Masumori N, Kato R, Hisasue S, Furuya R, Tsukamoto T (December 2009). "Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration". Int J Impot Res. 21 (5): 306–10. doi:10.1038/ijir.2009.27. PMC 2834370. PMID 19536124.

drugs.com

"Drugs.com, Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia". Retrieved 2008-02-13.

europa.eu

ema.europa.eu

"Silodyx EPAR". European Medicines Agency (EMA). 2010-01-10. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Urorec EPAR". European Medicines Agency. 2019-11-21.
"Urorec: EPAR – Product Information" (PDF). European Medicines Agency. 2019-11-21.

fda.gov

Fact Sheet for Healthcare Providers: Emergency Use Authorization for Paxlovid (Report). Pfizer. February 2023. p. 7.

accessdata.fda.gov

"Drug Approval Package: Rapaflo (Silodosin) NDA #022206". U.S. Food and Drug Administration (FDA). 14 November 2008. Retrieved 5 March 2023.

hres.ca

hpr-rps.hres.ca

"Summary Basis of Decision - Rapaflo". Health Canada. 4 May 2011. Retrieved 8 January 2021.

kissei.co.jp

"Kissei Acquired Marketing Approval for Urief Capsule, a Novel Drug for Dysuria associated with Benign Prostatic Hyperplasia". Kissei Pharmaceutical Co., Ltd. (Press release). 23 January 2006. Retrieved 5 March 2023.

nih.gov

dailymed.nlm.nih.gov

"Rapaflo- silodosin capsule". DailyMed. 1 December 2020. Retrieved 5 March 2023.

ncbi.nlm.nih.gov

Kobayashi K, Masumori N, Kato R, Hisasue S, Furuya R, Tsukamoto T (December 2009). "Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration". Int J Impot Res. 21 (5): 306–10. doi:10.1038/ijir.2009.27. PMC 2834370. PMID 19536124.

pubmed.ncbi.nlm.nih.gov

Kobayashi K, Masumori N, Kato R, Hisasue S, Furuya R, Tsukamoto T (December 2009). "Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration". Int J Impot Res. 21 (5): 306–10. doi:10.1038/ijir.2009.27. PMC 2834370. PMID 19536124.

tga.gov.au

"Prescription medicines: registration of new chemical entities in Australia, 2017". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 9 April 2023.
"Prescription medicines and biologicals: TGA annual summary 2017". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 31 March 2024.